产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 24014 | Zelasudil | 2365193-22-0 | ≧98.0% |  |
| Zelasudil 是一种有效的、高选择性的口服活性抑制剂，针对 Rho 相关 | ||||
| 24013 | Ziftomenib ( KO-539 ) | 2134675-36-6 | ≧98.0% | _2134675-36-6.png) |
| Ziftomenib 是一种口服、有效、选择性的小分子抑制剂，针对 menin 和 | ||||
| 24012 | Zunsemetinib | 1640282-42-3 | ≧98.0% |  |
| Zunsemetinib是一种在研口服丝裂原活化蛋白激酶活化蛋白激酶2（MK2 | ||||
| 24011 | Zongertinib ( BI 1810631 ) | 2728667-27-2 | ≧98.0% |  |
| Zongertinib [BI 1810631] 是一种人表皮生长因子受体 2 （HER2） 抑制剂。 | ||||
| 24010 | Zasocitinib | 2272904-53-5 | ≧98.0% |  |
| Zasocitinib是一种作用于非受体酪氨酸蛋白激酶 （TYK2）靶点的抑制 | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib（之前称为 INCB 00928）是一种激活素受体样激酶 2（ALK2， | ||||
| 20651 | Zatolmilast | 1606974-33-7 | 98% Min. |  |
| Zatolmilast is a phosphodiesterase IV inhibitor. | ||||
| 20628 | Zagociguat | 2201048-82-8 | 98% Min. |  |
| Zagociguat is a guanylate cyclase activator. | ||||
| 20610 | Zavondemstat | 1851412-93-5 | ≧98.0% |  |
| Zavondemstat 是一种 KDM4 抑制剂，具有抗肿瘤药物的潜力。 | ||||
| 20567 | 1Z105 | 1438280-73-9 | 98% Min. |  |
| 1Z105 is a TLR4/MD2 ligand, significantly reducing the IL-6 secretion by subsequent c | ||||
| 20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% |  |
| Zidesamtinib ( NVL-520 ) 是一种新型脑渗透性 ROS1 选择性酪氨酸激酶抑 | ||||
| 20513 | ZINC40099027 (ZN27) | 1211825-25-0 | ≧98.0% |  |
| ZINC40099027 (ZN27) 是一种特异性粘着斑激酶 (FAK) 激活剂，可促进缺血 | ||||
| 20446 | Zagociguat | 2201048-82-8 | 98% Min. | |
| Zagociguat is a guanylate cyclase activator. | ||||
| 20416 | N-苄氧羰基-L-丙氨酸 N-羟基琥珀酰亚胺酯 | 3401-36-3 | 98% Min. |  |
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131是下一代 ALK 抑制剂候选药物，目前正在我们针对 ALK+ 晚期 | ||||
| 20317 | Zipalertinib | 1661854-97-2 | 98% Min. |  |
| Zipalertinib, also known as TAS6417, CLN-081, is a Novel EGFR Inhibitor Targeting Exo | ||||
| 20301 | ZZW-115 | 801991-87-7 | 98% Min. |  |
| ZZW-115is a potent NUPR1 inhibitor. ZZW-115 induces ferroptosis in a mitochondria-dep | ||||
| 2071629 | (3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one | 486443-73-6 | 98% Min. | -5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one_486443-73-6.png) |
| LC3-mHTT-IN-AN1 (Compound AN1) is amHTT-LC3linker compound, which interacts with both | ||||
| 2071513 | ZK824859 | 2254001-81-3 | 98% Min. |  |
| ZK824859 is a potent uPA inhibitor as a potential treatment for multiple sclerosis. Z | ||||
| 193281 | ZL0454 | 2229042-77-5 | >98% |  |
| ZL0454是一种有效的选择性BRD4抑制剂。ZL0454减少气道炎症,抑制TLR3- | ||||
| 19352 | ZM223 | 2031177-48-5 | >98% |  |
| ZM223是一种新型非磺胺NEDD8激活酶抑制剂，对HCT116结肠癌细胞具有 | ||||
| 181233 | Z944 | 1199236-64-0 | >98% |  |
| Z944是一种T型钙通道拮抗剂，有望用于疼痛的治疗。Z944对癫痫大鼠 | ||||
| 189271 | Zamicastat | 1080028-80-3 | >98% |  |
| Zamicastat是一个强有力的和选择性的多巴胺β-mono-oxygenase抑制剂。 | ||||
| 185186 | 扎达维林 | 101975-10-4 | >98% |  |
| 扎达维林是一种磷酸二酯酶3/4抑制剂。 | ||||
| 18577 | Zanubrutinib | 1691249-45-2 | >98% |  |
| Zanubrutinib，也称为BGB-3111, 是一种有效且高选择性的小分子BTK抑制 | ||||
| 183213 | methyl 2-(4-(hydroxymethyl)phenyl)acetate | 155380-11-3 | >96% | 苯乙酸甲酯_155380-11-3.png) |
| Methyl 2-(4-(hydroxymethyl)phenyl)acetate is a drug Intermediate. | ||||
| 183212 | 2-(4-(Hydroxymethyl)phenyl)acetic acid | 73401-74-8 | >96% | 苯醋酸_73401-74-8.png) |
| 2-(4-(Hydroxymethyl)phenyl)acetic acid is a drug Intermediate. | ||||
| 183211 | 4-(Bromomethyl)phenylacetic acid | 13737-36-5 | >96% |  |
| 4-(Bromomethyl)phenylacetic acid is a drug Intermediate. | ||||
| 1712151 | GBR-12935 free base | 76778-22-8 | >98% |  |
| GBR-12935 is a piperazine derivative which is a potent and selective dopamine reuptak | ||||
| 1712142 | Etifoxine HCl | 56776-32-0 | >98% |  |
| Etifoxine, also known as HOE 36801 and etafenoxine, is an anxiolytic and anticonvulsa | ||||